Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

120 та иш

Иш: The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders

  1. Сарлавҳасиз

    Бошқа7 иқтибос
    ABI

  2. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

    Stephan A. Grupp, Michael Kalos, David M. Barrett +10

    Мақола20133 иқтибос
    ABI

  3. Сарлавҳасиз

    Бошқа3 иқтибос
    ABI

  4. CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

    Jianjun Chu, Youcai Deng, D.M. Benson +13

    Мақола20133 иқтибос
    ABI

  5. CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

    Joseph D. Malaer, Porunelloor A. Mathew

    Мақола20173 иқтибос
    ABI

  6. Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment

    Hila Magen, Eli Muchtar

    Шарҳ мақола20162 иқтибос
    ABI

  7. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion

    Jung-Mao Hsu, Weiya Xia, Yi‐Hsin Elsa Hsu +14

    Мақола20182 иқтибос
    ABI

  8. CAR T therapies in multiple myeloma: unleashing the future

    Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini +7

    Мақола20242 иқтибос
    ABI

  9. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission

    Mariola Kurowska‐Stolarska, Stefano Alivernini

    Шарҳ мақола20222 иқтибос
    ABI

  10. Immunopathogenesis of Rheumatoid Arthritis

    Gary S. Firestein, Iain B. McInnes

    Шарҳ мақола20172 иқтибос
    ABI

  11. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  12. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

    Joan Sayós, Chengbin Wu, M. Morra +11

    Мақола19982 иқтибос
    ABI

  13. SLAM family receptors in normal immunity and immune pathologies

    Ning Wu, André Veillette

    Шарҳ мақола20152 иқтибос
    ABI

  14. Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development

    Hooi-Yeen Yap, Sabrina Zi-Yi Tee, Magdelyn Mei-Theng Wong +3

    Шарҳ мақола20182 иқтибос
    ABI

  15. SLAM Family Receptor Signaling in Viral Infections: HIV and Beyond

    Patrick M. O’Connell, Andrea Amalfitano, Yasser A. Aldhamen

    Шарҳ мақола20192 иқтибос
    ABI

  16. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2

    Lisa von Wenserski, Christoph Schultheiß, Sarah Naomi Bolz +10

    Мақола20202 иқтибос
    ABI

  17. Diagnosis and Management of Multiple Myeloma

    Andrew J. Cowan, Damian J. Green, Mary Kwok +6

    Шарҳ мақола20222 иқтибос
    ABI

  18. SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus

    Morgane Humbel, Florence Bellanger, Alice Horisberger +8

    Мақола20222 иқтибос
    ABI

  19. Cancer treatment and survivorship statistics, 2022

    Kimberly D. Miller, Letícia Nogueira, Theresa P. Devasia +5

    Мақола20222 иқтибос
    ABI

  20. Global epidemiology of rheumatoid arthritis

    Axel Finckh, Benoît Gilbert, Bridget Hodkinson +5

    Шарҳ мақола20222 иқтибос
    ABI

  21. SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

    Emily Chu, Jian Wu, Stacey S. Kang +1

    Шарҳ мақола20232 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI